Inflammation and cancer: An ancient link with novel potentials
International Journal of Cancer2007Vol. 121(11), pp. 2373–2380
Citations Over TimeTop 1% of 2007 papers
Abstract
Infection and chronic inflammation contribute to about 1 in 4 of all cancer cases. Mediators of the inflammatory response, e.g., cytokines, free radicals, prostaglandins and growth factors, can induce genetic and epigenetic changes including point mutations in tumor suppressor genes, DNA methylation and post-translational modifications, causing alterations in critical pathways responsible for maintaining the normal cellular homeostasis and leading to the development and progression of cancer. Recent discovery of an interaction between microRNAs and innate immunity during inflammation has further strengthened the association between inflammation and cancer.
Related Papers
- → Mouse Models of Epigenetic Inheritance(2010)35 cited
- → Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders(2012)28 cited
- → Epigenetic Modifiers as Game Changers for Healthy Aging(2023)8 cited
- → The fifth dimension of innate immunity(2014)14 cited
- → Epigenetic Responses to Diet in Aging(2016)1 cited